Evidence map›Paper›PMID 36110997›Full record

ArticleAnnals of translational medicine2022

Landscape of

Guanghui Xu, Jiyang Zheng, Shu Wang, Yuhao Wang, Guixiang Li, Nan Wang, Xueke She, Weiming Duan, Hushan Zhang, Depei Huang and 3 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Guanghui Xu *Department of Digestive Surgery, Xijing Hospital, Air Force Medical University, Xi'an, China.
Jiyang Zheng *Department of Digestive Surgery, Xijing Hospital, Air Force Medical University, Xi'an, China.
Shu WangDepartment of Digestive Surgery, Xijing Hospital, Air Force Medical University, Xi'an, China.
Yuhao WangDepartment of Digestive Surgery, Xijing Hospital, Air Force Medical University, Xi'an, China.
Guixiang LiDepartment of Digestive Surgery, Xijing Hospital, Air Force Medical University, Xi'an, China.
Nan WangDepartment of Digestive Surgery, Xijing Hospital, Air Force Medical University, Xi'an, China.
Xueke SheThe Medical Department, 3D Medicines Inc., Shanghai, China.
Weiming DuanThe Medical Department, 3D Medicines Inc., Shanghai, China.
Hushan ZhangThe Medical Department, 3D Medicines Inc., Shanghai, China.
Depei HuangThe Medical Department, 3D Medicines Inc., Shanghai, China.
Ting BeiThe Medical Department, 3D Medicines Inc., Shanghai, China.
Dan FuThe Medical Department, 3D Medicines Inc., Shanghai, China.
Jianjun YangDepartment of Digestive Surgery, Xijing Hospital, Air Force Medical University, Xi'an, China.
Xijing Hospital · CNAir Force Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The human retinoblastoma susceptibility gene ( Methods: We investigated Results: Genomic alterations in Conclusions: Our findings indicate that

Indexed as

cyclin-dependent kinase 4/6 inhibitornext-generation sequencing (NGS)resistanceRetinoblastoma susceptibility gene (RB1)solid tumor

Identifiers

PMID36110997
PMCPMC9469137
OpenAlexW4292683571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.